The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Miguel Muniz discussing outcomes for 177 Lu-PSMA-617 with and without concurrent use of androgen receptor pathway ...

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...

ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...

A new study suggests that cancer risk may be shaped before birth, challenging the long-held belief that genetic mutations ...

Scientists in Cambridge have developed a new ?super test' for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients.

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

There is some good news for fans of Deadliest Catch as a beloved star of the show gave a positive health update. Captain ‘Wild’ Bill Wichrowski shared with fans the latest news following his prostate ...